Elago, Margaux Candice .
HRN: 15-76-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2024
CEFUROXIME 750MG (VIAL)
02/03/2024
02/09/2024
IV
730mg
Q8h
URTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes